Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion DiagnosticGlobeNewsWire • 07/08/20
Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology Drug DevelopmentGlobeNewsWire • 06/23/20
Guardant Health Presents Data at AACR Virtual Annual Meeting II Showing Liquid Biopsy Highly Accurate in Detecting Early-Stage Colorectal CancerGlobeNewsWire • 06/22/20
Guardant Health Announces Full Exercise of Option and Closing of Public OfferingGlobeNewsWire • 06/08/20
Investing $5,000 in These 3 Stocks Could Make You a Fortune Over the Next 10 YearsThe Motley Fool • 05/23/20
Guardant Health Data at ASCO and AACR Demonstrates Growing Value of Liquid Biopsy for Precision Oncology in Advanced and Early Stage CancerGlobeNewsWire • 05/15/20
Guardant Health Tops Buy Point; Even Pulled 2020 Outlook Is 'Achievable'Investors Business Daily • 05/08/20
Guardant Health, Inc. (GH) CEO Helmy Eltoukhy on Q1 2020 - Earnings Call TranscriptSeeking Alpha • 05/08/20
Guardant Health and Patient Advocacy Groups Join Forces to Raise Awareness of the Importance of Complete Biomarker Testing for Patients with Metastatic Non-Small Cell Lung CancerGlobeNewsWire • 05/05/20
3 Stocks to Buy Right Now That Could Triple Your Investment Within the Next 10 YearsThe Motley Fool • 04/26/20